Iswanto Sucandy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Iswanto Sucandy has a total of 427 co-authors. Here are the top co-authors by number of shared publications:
Sharona Ross
Digestive Health Institute, Hepatopancreatobiliary and Robotic Surgery, AdventHealth Tampa
58 shared publicationsAlexander Rosemurgy
Division Chief of Hepatopancreatobiliary Surgery, Digestive Health Institute, AdventHealth Tampa, 3000 Medical Park Drive, Suite # 500, Tampa, FL, 33613, USA
36 shared publicationsMaria Christodoulou
University of South Florida Morsani College of Medicine, Tampa, USA
20 shared publicationsSharona B. Ross
Digestive Health Institute Hepatopancreatobiliary (HPB) and Robotic Surgery, Division Chief of Hepatopancreatobiliary Surgery, Tampa, USA
20 shared publicationsCameron Syblis
University of South Florida Morsani College of Medicine, Tampa, FL, USA
18 shared publicationsKaitlyn Crespo
Digestive Health Institute, AdventHealth Tampa, Tampa, USA
15 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1936469
Open, laparoscopic, and robotic liver resection for hepatocellular carcinoma: evolving roles, comparative outcomes, and future perspectives
Hepatocellular carcinoma remains one of the leading causes of cancer-related mortality worldwide and frequently arises in the setting of chronic liver disease, cirrhosis, and portal hypertension. Liver resection represents a cornerstone of curative-intent treatment, but its role is uniquely influenced by the need to balance oncologic radicality with preservation of functional liver parenchyma. Over the last two decades, minimally invasive liver surgery has progressively expanded from selected laparoscopic minor resections to complex laparoscopic and robotic hepatectomies, challenging the historical dominance of open surgery. This narrative review critically examines the evolving roles of open, laparoscopic, and robotic liver resection for hepatocellular carcinoma, emphasizing patient selection, technical considerations, scenario-based platform choice, and comparative outcomes. Particular attention is given to hepatocellular carcinoma-specific challenges, including impaired liver function, clinically significant portal hypertension, future liver remnant adequacy, recurrence risk, and the need for parenchymal-sparing strategies. The review also discusses distinct clinical scenarios, including small solitary tumors, posterosuperior lesions, central or deeply located tumors, multifocal disease, and recurrent HCC. Current evidence consistently suggests that minimally invasive approaches are associated with reduced blood loss, fewer postoperative complications, and shorter hospital stay compared with open surgery, while maintaining comparable oncologic outcomes in selected patients. Laparoscopy remains the most established minimally invasive platform, whereas robotics may offer technical advantages in complex resections through improved dexterity, three-dimensional visualization, and enhanced suturing capability. However, available evidence remains largely retrospective and influenced by selection bias and institutional expertise. Platform selection should therefore be individualized according to tumor anatomy, liver function, technical complexity, and center experience, with the goal of maximizing oncologic benefit while minimizing functional liver loss.
- 8 October 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1936469
Open AccessOpen, laparoscopic, and robotic liver resection for hepatocellular carcinoma: evolving roles, comparative outcomes, and future perspectives
Hepatocellular carcinoma remains one of the leading causes of cancer-related mortality worldwide and frequently arises in the setting of chronic liver disease, cirrhosis, and portal hypertension. Liver resection represents a cornerstone of curative-intent treatment, but its role is uniquely influenced by the need to balance oncologic radicality with preservation of functional liver parenchyma. Over the last two decades, minimally invasive liver surgery has progressively expanded from selected laparoscopic minor resections to complex laparoscopic and robotic hepatectomies, challenging the historical dominance of open surgery. This narrative review critically examines the evolving roles of open, laparoscopic, and robotic liver resection for hepatocellular carcinoma, emphasizing patient selection, technical considerations, scenario-based platform choice, and comparative outcomes. Particular attention is given to hepatocellular carcinoma-specific challenges, including impaired liver function, clinically significant portal hypertension, future liver remnant adequacy, recurrence risk, and the need for parenchymal-sparing strategies. The review also discusses distinct clinical scenarios, including small solitary tumors, posterosuperior lesions, central or deeply located tumors, multifocal disease, and recurrent HCC. Current evidence consistently suggests that minimally invasive approaches are associated with reduced blood loss, fewer postoperative complications, and shorter hospital stay compared with open surgery, while maintaining comparable oncologic outcomes in selected patients. Laparoscopy remains the most established minimally invasive platform, whereas robotics may offer technical advantages in complex resections through improved dexterity, three-dimensional visualization, and enhanced suturing capability. However, available evidence remains largely retrospective and influenced by selection bias and institutional expertise. Platform selection should therefore be individualized according to tumor anatomy, liver function, technical complexity, and center experience, with the goal of maximizing oncologic benefit while minimizing functional liver loss.
- Open Access
- 1 October 2026
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 15 (5) , 144
Conversion therapy in locally advanced biliary tract cancer: expanding the boundaries of resectability using ZSAB-TransGOLP regimen
Conversion therapy in locally advanced biliary tract cancer: expanding the boundaries of resectability using ZSAB-TransGOLP regimen
- 1 October 2026
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 15 (5) , 144
Open AccessConversion therapy in locally advanced biliary tract cancer: expanding the boundaries of resectability using ZSAB-TransGOLP regimen
Conversion therapy in locally advanced biliary tract cancer: expanding the boundaries of resectability using ZSAB-TransGOLP regimen
- 2 August 2026
- Published by Springer Nature
- p. 55-59
Fibrolamellar Carcinoma
- 31 July 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (10) , 8989-8999
Safety of robotic liver resection under antiplatelet therapy: a propensity score-matching study
- 31 July 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (10) , 8989-8999
Safety of robotic liver resection under antiplatelet therapy: a propensity score-matching study
- 30 July 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (12) , 10082-10083
ASO Author Reflections: Preserving the Liver, Not Just Minimizing the Incision
- 30 July 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (12) , 10082-10083
ASO Author Reflections: Preserving the Liver, Not Just Minimizing the Incision
- Open Access
- 1 July 2026
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 11, 80
Intermittent inflow occlusion during robotic donor hepatectomy: technical refinement in a high-stakes operation through a randomized controlled trial
Intermittent inflow occlusion during robotic donor hepatectomy: technical refinement in a high-stakes operation through a randomized controlled trial
- 1 July 2026
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 11, 80
Open AccessIntermittent inflow occlusion during robotic donor hepatectomy: technical refinement in a high-stakes operation through a randomized controlled trial
Intermittent inflow occlusion during robotic donor hepatectomy: technical refinement in a high-stakes operation through a randomized controlled trial
- Open Access
- 18 June 2026
- Published by Wolters Kluwer Health in Annals of Surgery
Learning Curves and Complexity Evolution in Robotic Liver Surgery
Objective: To evaluate the institutional learning curve of robotic liver resection (RLR), its association with surgical complexity and outcomes in an international multicenter cohort. Summary of Background Data: RLR is increasingly adopted worldwide, but the dynamics of the learning process and its impact on surgical outcomes remain poorly defined. Methods: This international, multicenter, retrospective cohort study included consecutive patients who underwent RLR between 06/2013 and 12/2024 across 22 expert centers. Based on the first 150 cases at each center, three phases were used to define the learning curve: operative time for competency, major complications for proficiency, and textbook outcome for mastery. Risk-adjusted generalized additive models were used to assess the learning process. Benchmark performance was compared to international reference values. Results: Among 2,331 patients, the most common indications were hepatocellular carcinoma (36%), benign lesions (23%) and colorectal liver metastases (21%). Operative time decreased after achieving competency (case #62), from 240 to 220 minutes ( P P =0.144), while progression to mastery (cases #139–150) was associated with a higher rate of textbook outcome (76% vs. 87%, P =0.021). In contrast, conversion (5.1% vs. 4.9% vs. 2%), bile leak (4.0% vs. 5.3% vs. 3.8%), and 90-day mortality (0.7% vs. 0.9% vs. 0.9%) remained low and stable across all learning phases. Importantly, benchmark criteria for operative time, hospital stay, and textbook outcome were met across all complexity groups, including during the early learning phase. Conclusions: Robotic liver surgery shows progressive outcome improvement with early achievement of benchmark-level results and stable performance across increasing complexity. These findings indicate that, in experienced centers, RLR can be safely implemented and integrated into clinical practice, supporting its key role in modern hepatobiliary surgery.
- 18 June 2026
- Published by Wolters Kluwer Health in Annals of Surgery
Open AccessLearning Curves and Complexity Evolution in Robotic Liver Surgery
Objective: To evaluate the institutional learning curve of robotic liver resection (RLR), its association with surgical complexity and outcomes in an international multicenter cohort. Summary of Background Data: RLR is increasingly adopted worldwide, but the dynamics of the learning process and its impact on surgical outcomes remain poorly defined. Methods: This international, multicenter, retrospective cohort study included consecutive patients who underwent RLR between 06/2013 and 12/2024 across 22 expert centers. Based on the first 150 cases at each center, three phases were used to define the learning curve: operative time for competency, major complications for proficiency, and textbook outcome for mastery. Risk-adjusted generalized additive models were used to assess the learning process. Benchmark performance was compared to international reference values. Results: Among 2,331 patients, the most common indications were hepatocellular carcinoma (36%), benign lesions (23%) and colorectal liver metastases (21%). Operative time decreased after achieving competency (case #62), from 240 to 220 minutes ( P P =0.144), while progression to mastery (cases #139–150) was associated with a higher rate of textbook outcome (76% vs. 87%, P =0.021). In contrast, conversion (5.1% vs. 4.9% vs. 2%), bile leak (4.0% vs. 5.3% vs. 3.8%), and 90-day mortality (0.7% vs. 0.9% vs. 0.9%) remained low and stable across all learning phases. Importantly, benchmark criteria for operative time, hospital stay, and textbook outcome were met across all complexity groups, including during the early learning phase. Conclusions: Robotic liver surgery shows progressive outcome improvement with early achievement of benchmark-level results and stable performance across increasing complexity. These findings indicate that, in experienced centers, RLR can be safely implemented and integrated into clinical practice, supporting its key role in modern hepatobiliary surgery.
- 1 June 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1)
Technical complexity and perioperative outcomes of robotic central hepatectomy compared with right and left hepatectomy
Central hepatectomy (CH) is considered one of the most technically demanding robotic major liver resections because of the large transection plane and the proximity to major biliovascular structures. However, direct comparisons between robotic CH, right (RH), and left hepatectomy (LH) are lacking. This study evaluated differences in technical complexity and perioperative outcomes among these procedures. Robotic hepatectomies performed between 2013 and 2024 were retrospectively reviewed. Patients were stratified into CH, RH, and LH groups. Continuous variables were analyzed using the Kruskal-Wallis test, categorical variables using the Chi-square or Fisher's exact test, with Bonferroni correction for pairwise comparisons. Ninety-nine patients were included: 11 CH,39 RH, and 49 LH. Multifocal disease was more frequent in CH than in RH and LH (45.4% vs. 7.7% and 8.2%; P = 0.008). Operative time differed among groups (P = 0.0003), being longer in CH and RH than in LH. Estimated blood loss also differed (P = 0.0001), with higher values in CH and RH. Length of stay and major complications were comparable. No conversions or in-hospital mortality occurred. Robotic CH is performed in a more complex oncological setting but achieves perioperative outcomes comparable to RH and LH. However, RH is associated with a longer operative time and greater estimated blood loss.
- 1 June 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1)
Technical complexity and perioperative outcomes of robotic central hepatectomy compared with right and left hepatectomy
Central hepatectomy (CH) is considered one of the most technically demanding robotic major liver resections because of the large transection plane and the proximity to major biliovascular structures. However, direct comparisons between robotic CH, right (RH), and left hepatectomy (LH) are lacking. This study evaluated differences in technical complexity and perioperative outcomes among these procedures. Robotic hepatectomies performed between 2013 and 2024 were retrospectively reviewed. Patients were stratified into CH, RH, and LH groups. Continuous variables were analyzed using the Kruskal-Wallis test, categorical variables using the Chi-square or Fisher's exact test, with Bonferroni correction for pairwise comparisons. Ninety-nine patients were included: 11 CH,39 RH, and 49 LH. Multifocal disease was more frequent in CH than in RH and LH (45.4% vs. 7.7% and 8.2%; P = 0.008). Operative time differed among groups (P = 0.0003), being longer in CH and RH than in LH. Estimated blood loss also differed (P = 0.0001), with higher values in CH and RH. Length of stay and major complications were comparable. No conversions or in-hospital mortality occurred. Robotic CH is performed in a more complex oncological setting but achieves perioperative outcomes comparable to RH and LH. However, RH is associated with a longer operative time and greater estimated blood loss.